Cart
sales@molnova.com
Home - Products - Cell Cycle/DNA Damage - PARP - BYK204165

BYK204165

CAS No. 1104546-89-5

BYK204165( RT-017290 )

Catalog No. M21123 CAS No. 1104546-89-5

BYK204165 is a potent PARP inhibitor (PARP1; IC50 = 44.67 nM for human recombinant PARP1 in an enzyme assay).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 67 In Stock
5MG 61 In Stock
10MG 92 In Stock
25MG 170 In Stock
50MG 245 In Stock
100MG 361 In Stock
200MG 528 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    BYK204165
  • Note
    Research use only, not for human use.
  • Brief Description
    BYK204165 is a potent PARP inhibitor (PARP1; IC50 = 44.67 nM for human recombinant PARP1 in an enzyme assay).
  • Description
    BYK204165 is a potent PARP inhibitor (PARP1; IC50 = 44.67 nM for human recombinant PARP1 in an enzyme assay).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    RT-017290
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    PARP
  • Recptor
    PARP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1104546-89-5
  • Formula Weight
    252
  • Molecular Formula
    C15H12N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (495.50 mM; Need ultrasonic)
  • SMILES
    Cn1cccc1C=C1C(=O)NC(=O)c2ccccc21
  • Chemical Name
    (4Z)-4-[(1-methylpyrrol-2-yl)methylidene]isoquinoline-13-dione

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Eltze T Boer R Wagner T et al. Imidazoquinolinone imidazopyridine and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.[J]. molecular pharmacology 2008 74(6):1587-1598.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Senaparib

    Senaparib is a novel highly potent and selective oral PARP1/2 inhibitor with strong antitumor activity.

  • Fluzoparib

    fluzoparib is a novel, potent, and orally available inhibitor of PARP, potentially for the treatment of solid tumours.Fluzoparib potently inhibited PARP1 enzyme activity and induced DNA double-strand breaks, G2 /M arrest, and apoptosis in homologous recombination repair (HR)-deficient cells.?

  • SRI-011381

    SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer's disease.

Sign In Join Free